IPIC congresses are designed to put the patient interest at the center of all discussions. Alongside with many physicians and industry representatives, some patient organisation leaders with be attending. Differentiation of attendees will be done colour coding of the congress badges.
IPOPI strongly recommends that companies exhibiting at IPIC2023 always verify local regulations regarding exhibiting and distributing promotional materials at scientific meetings in the country where the congress is taking place. It should be noted that a dedicated are is reserved for the exhibition at IPIC2023 and that promotional items are clearly separated in the scientific programme. Most delegates at IPIC are doctors and other healthcare professionals. The organisers require all sponsoring and exhibiting companies to follow the European Federation of Pharmaceutical Industries and Associations – EFPIA – codes of conduct related to their participation at the IPIC2023 Congress.
IPIC2023 adheres to current industry compliance guidelines and follows transparency and integrity policies. The organisation always interacts with the industry on an ethical appropriate and professional level.
AIM Group International – IPIC2023 Organising Secretariat is appointed MEDTECH Trusted Partner. For any assistance please contact firstname.lastname@example.org
Official Italian Agency for AIFA Procedure
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124) in attached.
The request of authorization must be submitted within 60 days before the starting date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:
AIM Group International – AIM Education S.r.l.
Via G. Ripamonti, 129
20141 Milan, Italy
TEL +39 02 56601.1
FAX +39 02-70048585